News

License agreement between Nencki Institute and Teldoc Sp. z o. o.

03.09.2021

On August 31, 2021, prof. Agnieszka Dobrzyn, Nencki Institute’s Director, and Ms. Marta Kaleńska-Jaśkiewicz, Chief Executive Officer of Teldoc Sp. z o. o., signed a license agreement that defines the framework for Teldoc's use of the know-how and the IT system, which were developed within SONAR projects (SONAR system). SONAR system is a combination of a group testing strategy for SARS-CoV-2 diagnosis and an IT tool, which significantly improves practical implementation of the diagnostic ...

The Nencki Institute was awarded the statuette ‘HEART FOR HEART in the fight against coronavirus’

31.08.2021

In recognition of its contribution to the fight against SARS-CoV-2, the Nencki Institute has been awarded the 'HEART FOR HEART in the fight against coronavirus' statuette by the National Security ...

European patent granted for an invention from Nencki Institute and IIMCB

20.08.2021

The European Patent Office has issued a decision to grant a patent for an invention entitled “microRNA biomarkers in blood for diagnosis of Alzheimer's Disease” (EP3449009). The document claims a ...

Admission to the Nencki Institute

22.07.2021

The Nencki Institute of the Polish Academy of Sciences announces admission to the Warsaw PhD School in Natural and BioMedical Sciences [Warsaw-4-PhD] for the academic year 2021/2022. We ...

Research and development collaboration between Nencki Institute and Pikralida Sp. z o. o., to treat epileptogenesis

13.07.2021

Nencki Institute and Pikralida Sp. z o. o. collaborate on „Use of matrix metalloproteinase inhibitor to develop an innovative therapy of preventing the development of post-traumatic and ...